Expression of cytoplasmic p16 and anion exchanger 1 is associated with the invasion and absence of lymph metastasis in gastric carcinoma

Molecular Medicine Reports

Volumn 2, Issue 2, 2009, Pages 169-174

  Liu, Qiang ^a   Song, Ling Jun ^b   Xu, Wei Qing ^b   Zhao, Lei ^b   Zheng, Lin ^b   Yan, Zhao Wen ^b   Fu, Guo Hui ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Anion exchanger 1; Cytoplasmic p16; Gastric carcinoma; Invasion; Lymph metastasis

Indexed keywords

ERYTHROCYTE BAND 3 PROTEIN; PROTEIN P16; TUMOR SUPPRESSOR PROTEIN;

ADULT; ADVANCED CANCER; AGED; ANION EXCHANGE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL INVASION; CYTOPLASM; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CARCINOMA;

EID: 69249118633     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000079     Document Type: Article

References (32)

1. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 16: 704-707, 1993. (Pubitemid 24036021)
2. Kamb A, Gruis NA, Weaver-Feldhaus J, et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994. (Pubitemid 24986726)
3. Sherr CJ: Principles of tumor suppression. Cell 23: 235-246, 2004.
4. Fåhraeus R, Paramio JM, Ball KL, Laín S and Lane DP: Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Curr Biol 6: 84-91, 1996. (Pubitemid 126663443)
5. Reed AL, Califano J, Cairns P, et al: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56: 3630-3633, 1996. (Pubitemid 26272001)
6. Herman JG, Merlo A, Mao L, et al: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530, 1995.
7. Cairns P, Polascik TJ, Eby Y, et al: Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11: 210-212, 1995.
8. Muscarella P, Melvin WS, Fisher WE, et al: Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res 58: 237-240, 1998. (Pubitemid 28047061)
9. Salvesen HB, Das S and Akslen LA: Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Clin Cancer Res 6: 153-159, 2000. (Pubitemid 30064988)
10. Pei XH and Xiong Y: Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 24: 2787-2795, 2005.
11. Svensson S, Nilsson K, Ringberg A and Landberg G: Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res 63: 1737-1742, 2003. (Pubitemid 36460829)
12. Lux SE, John KM, Kopito RR and Lodish HF: Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1). Proc Natl Acad Sci USA 86: 9089-9093, 1989. (Pubitemid 20010370)
13. 2 transport. Acta Physiol Scand 182: 215-227, 2004.
14. Sterling D, Reithmeier RA and Casey JR: A transport metabolon. Functional interaction of carbonic anhydrase II and chloride/bicarbonate exchangers. J Biol Chem 276: 47886-47894, 2001. (Pubitemid 37370685)
15. Wang Y, Wu SF, Chen GQ and Fu GH: Effect of block deletions in the C-terminus on the functional expression of human anion exchanger 1 (AE1). Mol Membr Biol 24: 65-73, 2007. (Pubitemid 46261759)
16. Fu G, Wang T, Yang B, et al: Purification and characterization of the human erythrocyte band 3 protein C-terminal domain. Biochemistry 43: 1633-1638, 2004. (Pubitemid 38200569)
17. Cordat E, Li J and Reithmeier RA: Carboxyl-terminal truncations of human anion exchanger impair its trafficking to the plasma membrane. Traffic 4: 642-651, 2003. (Pubitemid 37062687)
18. Fu GH, Wang Y, Xi YH, et al: Direct interaction and cooperative role of tumor suppressor p16 with band 3 (AE1). FEBS Lett 579: 2105-2110, 2005. (Pubitemid 40469678)
19. Shen WW, Wu J, Cai L, Liu BY, Gao Y, Chen GQ and Fu GH: Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma. Neoplasia 9: 812-819, 2007. (Pubitemid 47623421)
20. Emig R, Magener A, Ehemann V, et al: Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with acce-erated tumour proliferation. Br J Cancer 78: 1661-1668, 1998. (Pubitemid 28550055)
21. Yamazaki T, Tomita S, Ichikawa K, et al: P16-immunostaining pattern as a predictive marker of lymph node metastasis and recurrence in early uterine cervical cancer. Pathobiology 73: 176-182, 2006. (Pubitemid 44808077)
22. Arifin MT, Hama S, Kajiwara Y, et al: Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas. J Neurooncol 77: 273-277, 2006. (Pubitemid 44404393)
23. Nilsson K and Landberg G: Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells. Int J Cancer 118: 1120-1125, 2006. (Pubitemid 43185597)
24. Straume O, Sviland L and Akslen LA: Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clin Cancer Res 6: 1845-1853, 2000.
25. Svensson Månsson S, Reis-Filho J and Landberg G: Transcriptional upregulation and unmethylation of the promoter region of p16 in invasive basal cell carcinoma cells and partial co-localization with the gamma 2 chain of laminin-332. J Pathol 212: 102-111, 2007. (Pubitemid 46746295)
26. Fabbro M, Rodriguez JA, Baer R and Henderson BR: BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J Biol Chem 277: 21315-21324, 2002. (Pubitemid 34952270)
27. Lee CT, Capodieci P, Osman I, et al: Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer. Clin Cancer Res 5: 977-983, 1999. (Pubitemid 29233210)
28. Ivanova TA, Golovina DA, Zavalishina LE, et al: Up-regulation of expression and lack of 5′ CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. BMC Cancer 7: 47-57, 2007.
29. Tryggvason K, Höyhtyä M and Pyke C: Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24: 209-218, 1993.
30. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 3: 1260-1270, 1997. (Pubitemid 27371946)
31. Salomao M, Zhang X, Yang Y, et al: Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc Natl Acad Sci USA 105: 8026-8031, 2008. (Pubitemid 351904701)
32. Morris MB and Lux SE: Characterization of the binary interaction between human erythrocyte protein 4.1 and actin. Eur J Biochem 231: 644-650, 1995.